AGA
Clinical trials for AGA explained in plain language.
Never miss a new study
Get alerted when new AGA trials appear
Sign up with your email to follow new studies for AGA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hair loss pill shows promise in early trial
Disease control OngoingThis study tests an experimental oral drug called VDPHL01 for people with mild to moderate male or female pattern baldness. The goal is to see if it is safe and can help regrow hair over 12 months. About 70 adults aged 18-65 will take a daily pill and have their hair growth measu…
Matched conditions: AGA
Phase: PHASE2 • Sponsor: Veradermics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New pill could regrow hair in balding men
Disease control OngoingThis study tests an experimental oral drug called VDPHL01 for male pattern baldness (androgenetic alopecia). About 480 men aged 18 to 65 with mild to moderate hair loss will take the drug or a placebo daily for about 13 months. The main goal is to see if the drug increases hair c…
Matched conditions: AGA
Phase: PHASE3 • Sponsor: Veradermics, Inc. • Aim: Disease control
Last updated May 07, 2026 18:42 UTC
-
New pill could help men regrow hair
Disease control OngoingThis study tests an experimental oral drug called VDPHL01 for male pattern baldness (androgenetic alopecia). About 480 men aged 18 to 65 with mild to moderate hair loss will take either the drug or a placebo for 6 months, then all will receive the active drug for another 6 months…
Matched conditions: AGA
Phase: PHASE2, PHASE3 • Sponsor: Veradermics, Inc. • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC